Agilent Technologies Inc. has announced a strategic partnership with PathAI to deliver biopharmaceutical organizations a solution that combines Agilent’s assay development expertise and PathAI’s algorithm development capabilities.

FUJIFILM Irvine Scientific, Inc. has announced the expansion of its BalanCD CHO Media Platform portfolio with the addition of two new, chemically defined growth media- BalanCD CHO Perfusion and BalanCD CHO DG44.

Cantargia has announced it will host an R&D Day focusing on new clinical results and biomarker data for its lead asset, the IL1RAP-binding antibody nadunolimab, in pancreatic cancer patients.

Evergreen Discovery and Orbit Discovery Ltd have announced that they have entered into a collaboration to identify specific cell targeting peptides and advance the development of novel radiopharmaceuticals.

Thermo Fisher Scientific and Arsenal Biosciences, Inc. have announced an update to their strategic collaboration to further the development of manufacturing processes for new cancer treatments.

 Thermo Fisher Scientific Inc. and the University of California, San Francisco will accelerate advanced cell therapies for difficult-to-treat conditions from a newly opened cGMP manufacturing facility.

Thermo Fisher Scientific is providing biopharmaceutical research laboratories with a new line of ion exchange columns that deliver superior reproducibility, sensitivity and durability for charge-based analysis of therapeutic proteins and separation of full vs. empty adeno-associated virus capsids.

With a small footprint of both large and small platforms, the Thermo Scientific™ Solaris™ Benchtop Temperature Controlled Orbital Shakers are designed to evolve alongside research and address a myriad of unmet laboratory needs.

Gyros Protein Technologies AB has announced the launch of three service offerings to support the development and manufacturing of peptide-based drugs.

Icosagen Group has announced that it has acquired the LSA® platform from Carterra®.